http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2354729-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_efd09c296645384c4e1c770411f7aa01 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-86 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-86 |
| filingDate | 2007-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2011-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b6099e451a308c4d487320f266167527 |
| publicationDate | 2011-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2354729-T3 |
| titleOfInvention | PROCEDURE FOR DETERMINING THE PLATELET FUNCTION AND FLOW CONDITIONS. |
| abstract | Procedure for determining platelet function in a whole blood sample, where the procedure comprises the following steps: a) conduction of blood through a capillary and, subsequently, through an opening of a separation element containing, at least one thrombocyte activator of the adenosine receptor activator group; and b) measurement of the time necessary for the formation of a thrombus in the opening of the separation element until the closure of said opening; characterized in that before passing through the capillary, the whole blood sample is mixed with prostaglandin E1 in a final concentration of 11 to 13 nM or with forskolin in a final concentration of 0.1 to 5 μM. |
| priorityDate | 2006-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 196.